Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.02 is 89% above its 5-year average of -0.18, near the high end of its 5-year range (-0.33–-0.02).
As of the fiscal period ended Tuesday, June 30, 2026. 83.24% above its 12-month average of -0.12.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-06-30): 0.06.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:42:21.647Z. Historical observations retain their original dates. Historical series through 2022-09-13.
EARNINGS PER SHARE (EPS)
-0.02
EARNINGS PER SHARE (EPS) AVG TTM
-0.12
EARNINGS PER SHARE (EPS) AVG 3Y
-0.17
EARNINGS PER SHARE (EPS) AVG 5Y
-0.18
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+83.24%
CURRENT VS 3Y AVG
+88.55%
CURRENT VS 5Y AVG
+88.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Innovage Holding Corp.
Market Cap
$1.22B
Earnings Per Share (EPS)
-0.02
TTM Avg
-0.12
3Y Avg
-0.17
5Y Avg
-0.18
Market Cap
$1.21B
Earnings Per Share (EPS)
0.18
TTM Avg
0.04
3Y Avg
-0.14
5Y Avg
-0.31
Market Cap
$1.19B
Earnings Per Share (EPS)
-0.14
TTM Avg
0.06
3Y Avg
-0.09
5Y Avg
-0.17
Market Cap
$1.17B
Earnings Per Share (EPS)
N/A
TTM Avg
-9.21
3Y Avg
-17.43
5Y Avg
-24.99
Market Cap
$1.16B
Earnings Per Share (EPS)
0.04
TTM Avg
0.06
3Y Avg
0.01
5Y Avg
-0.18
Market Cap
$1.13B
Earnings Per Share (EPS)
N/A
TTM Avg
-2.04
3Y Avg
-2.04
5Y Avg
-2.04
Market Cap
$1.13B
Earnings Per Share (EPS)
-124.78
TTM Avg
-85.76
3Y Avg
-67.06
5Y Avg
-58.99
Market Cap
$1.15B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.20
3Y Avg
-3.20
5Y Avg
-3.20
Market Cap
$1.11B
Earnings Per Share (EPS)
-0.99
TTM Avg
-0.32
3Y Avg
-0.47
5Y Avg
-0.45
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innovage Holding Corp. (INNV) | $1.22B | -0.02 | -0.12 | -0.17 | -0.18 |
| Cronos Group Inc. (CRON)vs › | $1.21B | 0.18 | 0.04 | -0.14 | -0.31 |
| MannKind Corporation (MNKD)vs › | $1.19B | -0.14 | 0.06 | -0.09 | -0.17 |
| Nektar Therapeutics (NKTR)vs › | $1.17B | N/A | -9.21 | -17.43 | -24.99 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 0.04 | 0.06 | 0.01 | -0.18 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | -2.04 | -2.04 | -2.04 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.13B | -124.78 | -85.76 | -67.06 | -58.99 |
| Kardigan, Inc. (KARD)vs › | $1.15B | N/A | -3.20 | -3.20 | -3.20 |
| Harrow Health, Inc. (HROW)vs › | $1.11B | -0.99 | -0.32 | -0.47 | -0.45 |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | -1.04 | -0.49 | -0.48 | -0.41 |
Trailing EPS (TTM)
$-0.02
Forward EPS (Est.)
$0.44
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-06-30 | -0.02 |
| 2025-06-30 | -0.22 |
| 2024-06-30 | -0.16 |
| 2023-06-30 | -0.30 |
| 2022-06-30 | -0.05 |
| 2021-06-30 | -0.33 |
| 2020-06-30 | 0.20 |
| 2019-06-30 | 0.15 |
